About Capecitabine
            
            Class: | Antimetabolite (specifically a pyrimidine analog)  
Use: | Treatment of metastatic breast cancer, colorectal cancer, and other solid tumors; often used as adjuvant therapy following surgery.  
Adult dose: | 1250 mg/m² orally twice daily for 14 days, followed by a 7-day rest period in a 21-day cycle; dosing may vary based on specific cancer type and patient tolerance.  
Pediatric dose: | Safety and efficacy not established; not recommended for use in pediatric patients.  
Side effects: |
         
        
            
                
                
                    
                        Drug Class
                    
                    Antimetabolite (specifically a pyrimidine analog)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of metastatic breast cancer, colorectal cancer, and other solid tumors; often used as adjuvant therapy following surgery.
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20-25°C or 68-77°F); protect from moisture and light; keep out of reach of children.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Pharmacare Premium Ltd; birzebbugia ,Malta, Malta
                    
                    
                    Package Size
                    120's [ 10's Blister x 12]
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 815.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        1250 mg/m² orally twice daily for 14 days, followed by a 7-day rest period in a 21-day cycle; dosing may vary based on specific cancer type and patient tolerance.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established; not recommended for use in pediatric patients.
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include nausea, vomiting, diarrhea, hand-foot syndrome (palmar-plantar erythrodysesthesia), fatigue, and mucositis.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to capecitabine or any of its components; severe renal impairment (creatinine clearance <30 mL/min); concomitant use with sorivudine or its analogs; pregnancy and breastfeeding.
         
        
        
            
                Important Warnings
            
            Risk of severe diarrhea, dehydration, and electrolyte imbalances; monitor for signs of hand-foot syndrome; caution in patients with hepatic impairment; may cause fetal harm; use effective contraception during treatment.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.